Inventor
SEUBERT PETER A
US23 patents
⚠️ This page may combine multiple inventors who share the name “SEUBERT PETER A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ELAN PHARM INC
9 patentsUS6114133ASep 5, 2000
Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)
ELAN PHARM INC187 citations98
US6284221B1Sep 4, 2001
Method for identifying β-amyloid peptide production inhibitors
ELAN PHARM INC132 citations97
US7928203B2Apr 19, 2011
Chimeric, humanized, or human antibody 2A4
ELAN PHARM INC38 citations96
US6018024AJan 25, 2000
Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
ELAN PHARM INC69 citations96
US7427392B1Sep 23, 2008
Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
ELAN PHARM INC22 citations92
US7186881B2Mar 6, 2007
Testing compounds for effects on synaptophysin in transgenic mice expressing an Alzheimer's disease FAD DNA sequence
ELAN PHARM INC23 citations91
US7811769B2Oct 12, 2010
Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
ELAN PHARM INC2 citations62
US7700309B2Apr 20, 2010
Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (X->41) and tau
ELAN PHARM INC1 citations62
US7993627B2Aug 9, 2011
Methods for determining whether a compound alters the amount of at least one αβ (X-41) peptide and the amount of either total αβ or at least one αβ (X-40) peptide produced by a non-human mammal
ELAN PHARM INC0 citations51
ATHENA NEUROSCIENCES INC
7 patentsUS5721130AFeb 24, 1998
Antibodies and fragments thereof which bind the carboxyl-terminus of an amino-terminal fragment of βAPP
ATHENA NEUROSCIENCES INC244 citations99
US5605811AFeb 25, 1997
Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
ATHENA NEUROSCIENCES INC180 citations99
US5441870AAug 15, 1995
Methods for monitoring cellular processing of β-amyloid precursor protein
ATHENA NEUROSCIENCES INC316 citations99
US5604102AFeb 18, 1997
Methods of screening for β-amyloid peptide production inhibitors
ATHENA NEUROSCIENCES INC165 citations98
US5837672ANov 17, 1998
Methods and compositions for the detection of soluble β-amyloid peptide
ATHENA NEUROSCIENCES INC185 citations97
US5424205AJun 13, 1995
Amyloidin protease and uses thereof
ATHENA NEUROSCIENCES INC71 citations94
US5292652AMar 8, 1994
Amyloidin protease and uses thereof
ATHENA NEUROSCIENCES INC36 citations91
SCHENK DALE B
4 patentsUS8791243B2Jul 29, 2014
Treatment and prophylaxis of amyloidosis
SCHENK DALE B8 citations84
US8404815B2Mar 26, 2013
Chimeric, humanized, or human antibody 2A4
SCHENK DALE B8 citations84
US8268973B2Sep 18, 2012
Anti-amyloid antibodies
SCHENK DALE B7 citations84
US8636981B2Jan 28, 2014
Detection of amyloid deposits using anti-amyloid antibodies
SCHENK DALE B2 citations63